Zacks Research Equities Analysts Raise Earnings Estimates for Tenet Healthcare Co. (NYSE:THC)

Tenet Healthcare Co. (NYSE:THC) – Equities researchers at Zacks Research lifted their Q3 2025 earnings estimates for Tenet Healthcare in a research note issued to investors on Wednesday, October 9th. Zacks Research analyst D. Chatterjee now anticipates that the company will earn $2.21 per share for the quarter, up from their previous forecast of $2.20. The consensus estimate for Tenet Healthcare’s current full-year earnings is $10.73 per share. Zacks Research also issued estimates for Tenet Healthcare’s FY2025 earnings at $9.67 EPS.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings data on Wednesday, July 24th. The company reported $2.31 EPS for the quarter, beating analysts’ consensus estimates of $1.89 by $0.42. Tenet Healthcare had a return on equity of 24.66% and a net margin of 13.17%. The firm had revenue of $5.10 billion for the quarter, compared to analyst estimates of $4.98 billion.

A number of other research firms also recently weighed in on THC. Truist Financial boosted their price target on shares of Tenet Healthcare from $170.00 to $180.00 and gave the stock a “buy” rating in a research note on Monday. Raymond James increased their price target on Tenet Healthcare from $130.00 to $175.00 and gave the company a “strong-buy” rating in a research note on Thursday, July 25th. Barclays lifted their price objective on Tenet Healthcare from $156.00 to $171.00 and gave the stock an “overweight” rating in a research note on Monday, July 29th. The Goldman Sachs Group raised their target price on Tenet Healthcare from $156.00 to $173.00 and gave the stock a “buy” rating in a report on Tuesday, July 30th. Finally, KeyCorp assumed coverage on Tenet Healthcare in a research note on Friday, October 11th. They issued an “overweight” rating and a $200.00 price target for the company. One investment analyst has rated the stock with a hold rating, fourteen have given a buy rating and four have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Buy” and an average target price of $156.06.

Tenet Healthcare Stock Performance

Shares of NYSE:THC opened at $160.26 on Monday. The stock has a market capitalization of $15.65 billion, a P/E ratio of 6.22, a P/E/G ratio of 0.78 and a beta of 2.14. The company has a current ratio of 1.45, a quick ratio of 1.38 and a debt-to-equity ratio of 2.53. Tenet Healthcare has a 1-year low of $51.04 and a 1-year high of $171.20. The business has a 50-day moving average price of $159.06 and a two-hundred day moving average price of $137.70.

Tenet Healthcare declared that its board has approved a share buyback program on Wednesday, July 24th that authorizes the company to buyback $1.50 billion in shares. This buyback authorization authorizes the company to purchase up to 10.3% of its shares through open market purchases. Shares buyback programs are usually an indication that the company’s board of directors believes its stock is undervalued.

Insider Activity

In related news, Director Meghan Fitzgerald sold 20,000 shares of Tenet Healthcare stock in a transaction that occurred on Tuesday, August 6th. The stock was sold at an average price of $146.34, for a total value of $2,926,800.00. Following the sale, the director now owns 15,269 shares of the company’s stock, valued at approximately $2,234,465.46. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, Director Meghan Fitzgerald sold 20,000 shares of the firm’s stock in a transaction on Tuesday, August 6th. The shares were sold at an average price of $146.34, for a total value of $2,926,800.00. Following the completion of the transaction, the director now owns 15,269 shares of the company’s stock, valued at approximately $2,234,465.46. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider R. Scott Ramsey sold 11,599 shares of the business’s stock in a transaction dated Thursday, September 5th. The stock was sold at an average price of $162.06, for a total transaction of $1,879,733.94. Following the sale, the insider now directly owns 6,324 shares in the company, valued at $1,024,867.44. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 128,203 shares of company stock worth $19,754,997 over the last three months. Corporate insiders own 0.93% of the company’s stock.

Institutional Investors Weigh In On Tenet Healthcare

Several large investors have recently made changes to their positions in the stock. Price T Rowe Associates Inc. MD lifted its stake in Tenet Healthcare by 11.1% in the first quarter. Price T Rowe Associates Inc. MD now owns 7,915,000 shares of the company’s stock valued at $831,947,000 after acquiring an additional 790,684 shares during the last quarter. 8 Knots Management LLC grew its holdings in Tenet Healthcare by 74.5% during the first quarter. 8 Knots Management LLC now owns 1,025,730 shares of the company’s stock worth $107,814,000 after purchasing an additional 438,033 shares during the period. Acadian Asset Management LLC raised its stake in Tenet Healthcare by 7,223.1% in the second quarter. Acadian Asset Management LLC now owns 326,244 shares of the company’s stock valued at $43,385,000 after buying an additional 321,789 shares during the period. Farallon Capital Management LLC boosted its stake in shares of Tenet Healthcare by 70.1% during the 1st quarter. Farallon Capital Management LLC now owns 637,442 shares of the company’s stock worth $67,002,000 after acquiring an additional 262,600 shares during the period. Finally, Kingdon Capital Management L.L.C. increased its holdings in shares of Tenet Healthcare by 335.8% during the 1st quarter. Kingdon Capital Management L.L.C. now owns 278,700 shares of the company’s stock worth $29,294,000 after acquiring an additional 214,750 shares during the last quarter. Institutional investors and hedge funds own 95.44% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.